Skip to main content
Log in

Systemic scleroderma has high economic burden

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 Australian dollars

  2. health-related quality of life

Reference

  • Morrisroe K, et al. Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life. Rheumatology : 9 Oct 2017. Available from: URL: http://doi.org/10.1093/rheumatology/kex362

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Systemic scleroderma has high economic burden. PharmacoEcon Outcomes News 792, 29 (2017). https://doi.org/10.1007/s40274-017-4552-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4552-0

Navigation